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Ectopic thyroid results from a migration defect of the developing gland during embryogenesis causing congenital hypothyroidism.
But it has also been detected in asymptomatic individuals. This study aimed to investigate the histopathological, functional, and
genetic features of human ectopic thyroids. Six samples were histologically examined, and the expression of the specific thyroid
proteins was assessed by immunohistochemistry. Two samples were submitted to whole exome sequencing. An oropharynx
sample showed immature fetal architecture tissue with clusters or cords of oval thyrocytes and small follicles; one sample
exhibited a normal thyroid pattern while four showed colloid goiter. All ectopic thyroids expressed the specific thyroid genes
and T4 at similar locations to those observed in normal thyroid. No somatic mutations associated with ectopic thyroid were
found. This is the first immature thyroid fetal tissue observed in an ectopic thyroid due to the arrest of structural differentiation
early in the colloid stage of development that proved able to synthesize thyroid hormone but not to respond to TSH. Despite the
ability of all ectopic thyroids to synthetize specific thyroid proteins and T4, at some point in life, it may be insufficient to
support body growth leading to hypothyroidism, as observed in some of the patients.
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1. Introduction
The thyroid gland is a bilobar gland composed of two endo-
crine cells, namely, the thyroid follicular cells (TFCs) that
produce the thyroid hormones T3 and T4 and the parafolli-
cular cells that secrete calcitonin. TFCs are derived from
the thyroid primordium, or thyroid anlage, that originates
from a thickening of the endodermal epithelium in the fore-
gut at the base of the prospective tongue. This structure
develops the thyroid diverticulum that proliferates, invades
the surrounding mesenchyme, and migrates through the
anterior midline of the neck. During migration, the primitive
thyroid acquires a bilobed structure while the thyroglossal
duct, the initial connection to the primitive pharyngeal floor,
loses its lumen and turns into disconnected fragments.
When the developing thyroid reaches its final position at
the base of the neck in front of the trachea, the fusion of
the ultimobranchial bodies takes place to give rise to C cells.
Finally, folliculogenesis occurs concomitantly with differen-
tiation of thyroid progenitor cells into functional thyroid fol-
licular cells, expressing specific thyroid genes such as TSH
receptor (TSHR), Na/I symporter (NIS), and thyroglobulin
(TG) [1–3].
In mouse models, normal embryogenesis of the thyroid
was shown to be controlled by a well-integrated regulatory
network of transcription factors [4, 5]. During the formation
of the thyroid anlage (specification phase), the expression of
thyroid transcription factors TITF1, PAX8, FOXE1, and
HEX1 can be observed. FOXE1 is believed to be required
for migration of the mouse thyroid primordium after detach-
ment of the bud [6], and survival of the thyroid primordium
depends on the expression of FOXE1 and PAX8 [4].
Ectopic thyroid is a rare malformation that results
from a migration defect of the developing gland during
embryogenesis [1]. The glands can be found at any point
along the path of migration, from the foramen cecum to
the mediastinum, and also in distal subdiaphragmatic areas.
However, the most frequent site is at the base of the tongue
or lingual thyroid [7]. Ectopia is the most common form
of thyroid dysgenesis (TD) and congenital hypothyroidism
[8, 9] but has also been detected in asymptomatic individuals
or as a cause of hypothyroidism, dysphonia, dysphagia,
cough, snoring, or sleep apnea and coexisting with a normally
located thyroid [10–12] [13, 14].
The pathogenesis of ectopic thyroid, and the fact that
some ectopic patients remain euthyroid throughout life,
has not yet been elucidated. Few studies have character-
ized the expression of important thyroid proteins [10, 14].
In addition, mutations in genes FOXE1, PAX8, TSHR,
NKX2.1, or NKX2.5 associated with TD were identified in
only 2-3% of TD cases [15]. Recently, with whole exome
sequencing (WES), a powerful tool for investigating genetic
causes of human diseases, novel genes were identified in
TD cases [16, 17].
Thus, the aim of the present study was to investigate the
histopathological and functional characteristics of human
ectopic thyroid tissues through the expression of T4, specific
thyroid proteins TG, NIS, TSHR, and thyroid transcription
factors NKX2.1 and PAX8 by immunohistochemistry and
to identify potential pathogenic mutations with expanded
whole exome sequencing.
2. Material and Methods
2.1. Samples. Paraffin blocks of four human ectopic thyroid
samples were retrospectively collected from patients who
underwent thyroid resection, and two flash-frozen tissue
samples removed due to symptoms (sample 4) or suspicious
cytology for papillary thyroid lesion (patient 2) were also
included in the study. The control sample was taken from
archived paraffin blocks of the normal thyroid. The study
protocol was approved by the local Research Ethics Commit-
tees (HC 893/01 and CEP 1078/11).
2.2. Patients. All patients were born before the establishment
of the mandatory Neonatal Screening Program in Brazil,
except for patient 5. Clinicopathologic information on the
ectopic patients was obtained from medical records. Patient
1 is a 34-year-old female with an oropharyngeal ectopic
thyroid mass detected at 7 years of age. The patient was never
treated with levothyroxine (LT4) and had two cesarean deliv-
eries. Preoperative thyroid hormonal status was TSH:
11.19mIU/L (ref. 0.5–4.2mIU/L), and total T4: 2.48μg/dL
(ref. 5.3–12.6μg/dL) (to convert to nmol/L, multiply by
12.87). Patient 2 is a 46-year-old female with ectopic thyroid
located at the hyoid bone. The patient had been treated with
LT4 (100μg/day) for hypothyroidism for the last 30 years.
Goiter was diagnosed 4 years before surgery. Patient 3 is a
7-year-old euthyroid girl. Lingual thyroid was detected at 5
years of age when investigating swallowing and sleeping dif-
ficulties. The patient was never treated with LT4. Patient 4 is
a 38-year-old male with lingual thyroid causing excessive
snoring. The patient was never treated with LT4, and preop-
erative thyroid hormonal status was FT4: 0.6 ng/dL (ref. 0.6–
1.54 ng/dL) (to convert to pmol/L, multiply by 12.87), TSH:
46.7mIU/L (ref. 0.5–4.2mIU/L), and negative anti-TPO
and anti-Tg. Patient 5 is a one-month-old girl with midline
defect and lingual thyroid, diagnosed after surgery for sus-
pected lingual tumor. Neonatal test after surgery indicated
TSH> 200mIU/L. Patient 6 is a 13-year-old girl with a neck
nodule noted at birth that grew during childhood develop-
ment. At 11 years of age, lingual thyroid was diagnosed and
hypothyroidism confirmed with serum TSH: 11.42mIU/L,
FT4: 0.73 ng/dL (ref. 0.897–1.794 ng/dL), and negative anti-
TPO. Levothyroxine was prescribed, but the patient showed
poor compliance.
2.3. Immunohistochemistry. Three μm thick sections of
formalin-fixed and paraffin-embedded tissue samples from
the six patients (samples 1–6) were first stained with
hematoxylin/eosin for histological observation and then
submitted to immunohistochemical procedures. Antigen
retrieval was performed in 10mM citrate buffer/pH6.0 in
a pressure cooker for three minutes, and endogenous per-
oxidase was inactivated in 6% hydrogen peroxide solution
in an incubation step. The antibodies used in this study
were monoclonal anti-thyroid peroxidase (TPO) (MoAb47,
1 : 500, DakoCytomation, Glostrup, Denmark), monoclonal
2 International Journal of Endocrinology
anti-sodium-iodide symporter (NIS) (FP5A, 1 : 200, Mayo
Clinic, USA), monoclonal anti-TTF1 (NKX2.1) (8G7G3/1,
1 : 500, Cell Marque, Rocklin, USA), monoclonal anti-
thyroid-stimulating hormone receptor (TSHR) (4C1/E1/G8,
1 : 200, NeoMarkers, Fremont, USA), polyclonal anti-PAX8
(rabbit, 1 : 500, Cell Marque), polyclonal anti-thyroglobulin
(rabbit, 1 : 400.000; DakoCytomation), and polyclonal
anti-thyroxine (T4) (rabbit, 1 : 1.000; Cloud-Clone Corp.,
Houston, USA). Tissue sections were incubated overnight
with the primary antibodies, and amplifications were
obtained by peroxidase-conjugated polymer (Ultravision
TL015-HDS, Thermo Fisher Scientific, Fremont, USA) and
then revealed by diaminobenzidine/hydrogen peroxide
substrate chromogen. Images were acquired using a Leica
TCS SP8 microscope. The samples were examined by two
of the authors.
2.4. Whole Exome Sequencing and Analysis. Total DNA from
ectopic tissue from patients 2 and 4 was used to prepare the
DNA library with Agilent SureSelectXT reagent kit (Agilent
Technologies®, Santa Clara, USA), and the whole exome
and UTR regions were sequenced in Illumina NextSeq 500
platform (Illumina® Inc., San Diego, USA) with a calculated
coverage average of 140x per sample. Sequenced reads
were aligned to a reference genome (GRCh37/hg19) using
Burrows-Wheeler Alignment (BWA), and calling was per-
formed with Genome Analysis Toolkit (GATK). Single
nucleic variants and small insertions-deletions were anno-
tated with ANNOVAR [18]. Data were filtered with 12
sample controls of Brazilian familial thyroid cancer tissues,
variants with low-quality score, and common variants
(MAF> 1%), and neutral variants were eliminated. Pre-
dictions of deleterious effect were evaluated using online
bioinformatics tools: SIFT, PolyPhen-2, mutationassessor,
fathmm, Condel, MutationTaster, and PROVEAN [19–21].
3. Results
3.1. Histopathology of Ectopic Thyroids. Fetal thyroid archi-
tecture was observed in sample 1 which exhibited isolated
epithelial oval cells that were unpolarized or arranged in clus-
ters and cords and primitive small follicles lined by cuboidal
cells with a small lumen, some of them with colloid embed-
ded in stroma (Figures 1 and 2). Small areas of the section
with normal-sized follicles were also observed.
Histopathological examination of samples 2, 3, 4, and 6
revealed colloid goiter with highly enlarged follicles lined by
flattened epithelial cells (Figure 2(A)). Focal areas (10–25%)
composed of normal-sized follicles with cuboidal cells were
also detected in these samples. Sample 5 showed normal
thyroid tissue (Figure 2(B)).
3.2. Immunohistochemistry Expression. TG expression was
intense and diffuse in the lumen of all follicles of the samples
under investigation, even in microfollicles from tissue with
fetal architecture (sample 1). Cytoplasmic TG staining was
weak or negative in the normal-sized follicles and also in
the macrofollicles of the ectopic samples, similarly to nor-
mal thyroid sample. However, strong cytoplasmic staining
was observed in isolated thyrocytes and microfollicles
from the fetal thyroid tissue (sample 1) (Figures 1(a), 1(b),
and 2, a–c).
TPO staining was strong and diffuse within the cyto-
plasm of thyrocytes and was also observed in the apical mem-
brane of all follicles of the ectopic samples examined, similar
to normal thyroid tissue. Only cytoplasmic TPO was
observed in isolated thyrocytes from fetal thyroid tissue
(sample 1) (Figures 1(c) and 2, d–f).
TSHR expression was intense and scattered within the
cytoplasm of thyrocytes of the ectopic samples, akin to a nor-
mal sample (Figures 1(d) and 2, g–i).
NKX2.1 diffuse immunostaining was strong in the
majority of the nuclei of the ectopic thyroid samples, except
for sample 2 which had approximately 10% low positive
nuclei and scattered cytoplasmic expression. Low expression
was observed in most of the nuclei of normal thyroid
(Figures 1(e) and 2, j–l).
PAX8 moderate to intense diffuse expression was
observed for all ectopic samples in approximately 70–80%
of follicular cell nuclei, except for sample 2 which had a low
expression in around 20% of nuclei and scattered cytoplas-
mic expression. Expression in normal thyroid tissue was
low in most of the nuclei (Figures 1(f) and 2, m–o).
NIS was positive in the basolateral membrane in up to
10% of the cells of ectopic samples 3, 4, and 5. Cytoplas-
mic staining was observed in all samples. Normal thyroid
sample had a similar pattern of 20% positivity in the baso-
lateral membrane and cytoplasmic staining (Figures 1(g)
and 2, p–r).
T4 expression was diffuse and intense in colloid of micro-
and normal-sized follicles from the fetal thyroid sample
(Figure 1(h)). In the other ectopic samples, the colloid T4
expression was moderate or intense, although some follicles
showed low or negative immunostaining, similarly to normal
thyroid (Figure 2, s–u).
3.3. Whole Exome Sequencing. After filtering the sequencing
data, 3501 and 3287 variants (indel or SNVs) were identified
in samples 2 and 4, respectively. The approaches to select
deleterious mutations were (a) identification of common
variants, (b) investigation of homozygous alterations (161
and 165, resp.) due to a possible recessive pattern of inheri-
tance, (c) the candidate gene approach along with a list of
190 genes related to development and thyroid function
(Table 1) [22–34] because no family members were available,
and (d) identification of variants in the 5’UTRs of genes with
binding motifs for FOXE1 (Table 2) [35, 36] and PAX8
(Table 3) [37] because these transcription factors are
expressed from the early stages of thyroid embryogenesis.
None of the selected variants were predicted deleterious by
the specific programs. Thus, this analysis did not identify
somatic mutations in the sequenced regions that could corre-
late with the disease.
4. Discussion
Ectopic thyroid has a prevalence of 1 : 100,000–300,000 indi-
viduals and 1 : 4000–8000 among patients with thyroid





Figure 1: Hematoxylin/eosin staining (a) (10x) and immunohistochemistry expression of specific thyroid genes in ectopic thyroid tissue
sample 1 showing fetal architecture with clusters, cords and isolated epithelial oval cells, small follicles lined by cuboidal cells, and small
areas of normal-sized follicles (b–h) (40x). TG: intense diffuse expression in the lumen of follicles and in cytoplasm of microfollicles and
isolated thyrocytes (b). TPO: intense immunostaining in the apical membrane of micro- and normal-sized follicles; cytoplasmic TPO was
observed in follicular cells and isolated thyrocytes (c). TSHR: scattered staining in the cytoplasm of thyrocytes (d). NKX2.1: strong diffuse
nuclear immunostaining observed in most nuclei (e). PAX8: moderate or intense expression observed in around 80% of nuclei (f). NIS:
diffuse cytoplasmic staining observed (g). Thyroxine (T4): diffuse and intense expression observed in the colloid of micro- and normal-
sized follicles (h).
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colloid goiter









Figure 2: Immunohistochemistry expression of specific thyroid genes in ectopic and normal thyroid tissue. (A) Representative images of
samples 2, 3, 4, and 6 showing goiter; (B) sample 5 exhibiting normal thyroid pattern; and (C) normal thyroid sample. TG: intense diffuse
TG expression in the lumen of all follicles of the ectopic and normal samples; weak or negative cytoplasmic staining in cell follicles (a–c).
TPO: intense immunostaining in the cytoplasm of thyrocytes and in the apical membrane of the follicles of ectopic samples examined,
similar to the normal thyroid sample (d–f). TSHR: scattered staining in the cytoplasm of thyrocytes in ectopic and normal samples (g–i);
magnified representative image showing basolateral membrane staining in some cells. NKX2.1: strong diffuse nuclear immunostaining was
observed in most of the nuclei of the ectopic and normal thyroid tissues (j–l), except for sample 2, showing 10% positive nuclei. PAX8:
moderate expression observed in around 80% of nuclei of normal and ectopic thyroid tissues (m–o) with focal areas of low nuclear
expression in the ectopic samples. In sample 2, only 20% of positive nuclei were positive and scattered cytoplasmic expression was also
observed. NIS: cytoplasmic staining was observed in all samples (p–r), and basolateral membrane positivity was observed in up to 10% of
cells of samples 3, 4, and 5 (p, q). Normal samples had a similar pattern of 20% positivity in the basolateral membrane and cytoplasmic
staining (r). Thyroxine (T4): moderate or intense diffuse expression in follicular colloid was observed, although some follicles showed low
immunostaining, similar to the normal thyroid (s–u). Magnification at 40x except for the images of a, c, s, and u at 20x.
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disease [7] and is more frequent among females (65–80%)
[38] while age at diagnosis ranges from the neonatal period
to adult life. In terms of thyroid function, patients can pres-
ent hypothyroid, euthyroidism, and, more rarely, hyperthy-
roidism [7, 14, 39].
In the present study, we investigated six ectopic thyroid
samples: four were lingual thyroids, one was located at the
oropharynx, and another at the hyoid bone. The histology
of previously reported ectopic thyroid cases have shown a
normal thyroid follicular pattern [10, 40] and a predisposi-
tion for similar abnormalities to those observed in normal-
positioned glands, such as follicular adenoma, colloid goiter,
and others [14, 41–45]. In the present study, the histopatho-
logical examination of the ectopic thyroid tissue from one
adult patient (sample 1) disclosed an immature fetal architec-
ture pattern characterized by the presence of clusters and
cords of epithelial oval unpolarized cells, primitive follicles,
and small follicles embedded in stroma with small areas of
normal-sized follicles [27, 46]. Thyroid tissue with fetal-like
appearance was previously identified in an apparently unaf-
fected mother of congenital hypothyroid children associated
with a heterozygous PAX8 mutation [47]. Although no
mutational investigation was performed, the immunohisto-
chemistry examination showed strong nuclear PAX8 expres-
sion in around 80% of the cells of this tissue. It remains to be
investigated whether this is a functional protein. The other
ectopic samples exhibited normal thyroid features (sample
5) or colloid goiter patterns (samples 2, 3, 4, and 6).
All ectopic samples expressed T4 and the specific thyroid
proteins TPO, TG, TSHR, PAX8, NKX2.1, and NIS, although
focal follicles, tissue areas, or thyrocytes within follicles failed
to express several of these proteins (data not shown). A het-
erogeneous expression pattern was also observed in normal
Table 1: Candidate genes related to development and thyroid
function (gene symbol) [22–34].
ABCA13 DIO2 FOXE3 KDR SFRP1
ACP2 DKK3 FOXQ1 KLF4 SFRP2
ACTA1 DMD FRS2 KPNA4 SFRS2
AKT1 DTX4 FRS2A LAMA4 SHH
AKT3 DUOX1 FRZB LEFTY1 SIX1
ANKRD36B DUOX2 FXR1 LHX3 SLC26A4
ARHGEF6 DUOXA1 FZD1 LHX4 SLC5A5
ASPM DUOXA2 FZD3 LMO3 SMAD3
ATP2A1 DUSP6 FZD4 LRP8 SMAD5
BCL2L1 EDN1 GATA5 LYZ SMAD9
BCL2L12 EDN3 GJA1 MKI67 SMOC2
BGN EEF1A2 GLIS3 MKRN1 SNX1
BMP4 EFNB2 GNG5 MS4A6A SOX17
C9orf70 EGFR GPNMB MTHFD2 SOX9
CCND1 EGR1 GSTT1 MUC1 SPRED1
CDC42EP4 EMP3 HADHA MYBPC1 TAL1
CDH16 ENO3 HAND2 MYL2 TAZ
CDH2 EVC2 HES1 NAV1 TBX1
CEBPB EYA1 HESX1 NKX2.1 TCAP
CECR1 FAU HHEX NKX2.5 TCF4
CFC1B FBLN1 HLA-DQA1 NLK TEF
CGA FGF10 HLA-DQB1 PABPC1 TG
CHGA FGF12 HOXA2 PAX2 TGFB2
CHORDC1 FGF2 HOXA3 PAX8 THRA
CKM FGF3 HOXA5 PBX4 THRB
CLDN5 FGF8 HOXB3 PCSK2 THRSP
CNTN6 FGFR1 HOXD3 PITX2 TNFAIP2
COL1A1 FGFR2 HSPA1B PKNOX1 TNFRSF21
COL3A1 FGL2 IGHG4 PLCXD1 TNNC2
CPEB4 FLJ11127 IGJ PLEKHA3 TPO
CREB1 FLJ32115 IGSF1 PLXND1 TRA
CTGF FMR1 INHBB POLD4 TRH
CTNNAL1 FN1 INSL3 PRKCE TSHb
CXCL12 FOS ISL1 PROP1 TSHR
CXCR4 FOSB ISL2 RARRES1 TWSG1
CYBB FOXA1 IYD RASD1 TXNIP
CYBRD1 FOXA2 JAG1 RNASE6 TYROBP
DIO1 FOXE1 JAG3 ROBO4 VEGFA
Table 2: Target genes of the transcription factor FOXE1 (gene
symbol) [35, 36].
ADAMTS9 CRIP2 ENGASE IL23A RT1-DA
AHCY CTGF ERO1LB KRT20 S100A4
AMIGO3 DDIT3 ETV5 MANF SDF2L1
ANKRD37 DERL3 FGF18 MFSD2 SEC23B
ATMIN DNAJB11 FOLR1 NR4A2 SEL1L
BCAM DNAJB9 GGCT NUPR1 SLIT1
BET1 DNAJC3 GMPPB PDIA4 TM4SF1
CASP4 DUOX2 HSP90B1 PRIMA1 TMEM140
CDH1 DUSP5 HSPA5 PRSS8 TMEM66
COQ10B DYNLRB2 HYOU1 RIL ZFAND2A
CRELD2 ELOVL2 IGF2BP2 RIOK3
Table 3: Target genes of the transcription factor PAX8 (gene
symbol) [37].
ACOT2 CFD GCSH LACTB RASSF2
ACY1 CITED2 GJA4 LRP8 RSAD2
ADAMTS9 CRYAB GSTP1 LRRC58 RUNX2
ALCAM CTGF HACD4 NFKB1 SLC26A7
ANKRD9 CXCL1 HSD17B1 NR3C2 SMIM22
ARHGAP22 DGAT2 IGFBP5 NRIP3 SPARC
BHLHE40 EGR1 IGFBP7 NUP107 STS
BRAF EIF4E IRGQ OPRK1 TAZ
CAMK1G ENPP1 JUN OSTALPHA TEKT4
CAMKK2 F10 KCNJ15 PBLD TG
CD47 FAM13A KCNJ16 POMT1 TMEM140
CDA FGFR2 KCNK1 PRR5L TRIB1
CDH16 FOXE1 KRT14 RAB17 WBP2
CDH16 GALK2 KRT7 RASL10A WNT4
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thyroid tissues and has been related to morphological fea-
tures and the ability of thyrocytes and follicles to concentrate
iodine [48, 49]. Sample 2 had low nuclear expression of PAX8
and NKX2.1 and scattered cytoplasmic immunostaining;
however, no somatic mutations were detected by WES. Both
genes have been linked to thyroid development [3] and are
expressed in the thyroid anlage when migration initiates
[50], and mutations have been associated with few TD cases
[51]. On the other hand, in ectopia, high PAX8 expression
was associated to the activation state of the gland [22], and
high expression of NKX2.1 was related to abnormal embryo-
genesis [14]. Thus, further studies assessing the significance
of the observed data are warranted.
The location of the specific thyroid proteins was similar
to that observed in normal thyroid [22, 52]. The cytoplasmic
TSHR staining may have been due to the use of an antibody
against the extracellular domain of this protein, as previously
described [53]. Likewise, the cytoplasmic NIS localization in
all the samples and the membrane immunostaining in four
of them was in accordance with previous reports [27, 46, 54].
Previous transcriptome analysis showed no difference in
the expression of specific thyroid genes between ectopic
and normal thyroid tissue when corrected for TSH levels
[22]. Despite the protein expression data not being corrected
for TSH levels, our results confirm the expression and the
appropriate localization of these proteins in ectopia, includ-
ing T4. More interestingly, they confirm that primitive folli-
cles in sample 1 were able to synthetize T4, asserting the
functional status of the gland, although it may have been
unable to respond to TSH.
The clinical data of the patients suggest that the ectopic
thyroids have been able to synthetize adequate amounts of
thyroid hormone at least early in the patient’s life. Neverthe-
less, the amount of secreted thyroid hormone might not be
sufficient to meet the body’s needs during growth, promoting
hypothyroidism, given that hormone requirement is based
on body weight [55]. The low hormone production may be
a consequence of the small size of the ectopic glands, possibly
due to the migration defect, and of a limitation in TSH-
induced growth [14].
Human thyroid morphogenesis begins at 22 days of preg-
nancy and is largely complete when reaching its final position
in front of the trachea at 7 gestational weeks (GW) (48 days
of pregnancy). At this point, the thyroid is composed of
undifferentiated thyrocytes and expresses strong PAX8 and
weak NKX2.1 and FOXE1 [2, 50]. Subsequently, the struc-
tural and functional differentiations of the thyroid ensue,
accompanied by precisely timed expression of the specific
thyroid genes and can be divided into three stages. First is
the precolloid stage (7 to 10 GW), with a large number of
cords or clusters of undifferentiated thyrocytes expressing
PAX8, FOXE1, NKX2.1, and cytoplasmic TG and TSHR,
while expression of NIS and TPO is not observed. Second is
the beginning of the colloid stage (10 to 11 GW) with devel-
oping small follicles with polarizing thyrocytes that express
TPO in the apical membrane, TSHR in the basolateral mem-
brane, NIS in cytoplasm, and TG in follicular lumen and cul-
minates with T4 synthesis. The third stage is the follicular
growth stage (from 12 GW forth) with the basolateral
membrane expression of NIS [27, 46]. Thus, our data allow
us to hypothesize that at least three different impairments
in thyroid development may have led to ectopic thyroid.
In patient 1, a premature arrest of migration (33–48 days
of gestation) may have led to positioning of the gland at the
oropharyngeal level [1] with a subsequent arrest of the struc-
tural differentiation during the early colloid stage [1, 46],
resulting in a nonhomogeneous fetal thyroid tissue pattern
able to synthetize T4. Second, in patient 2, the migration of
the developing gland may have also stopped before reaching
its final position, resulting in the thyroid positioned at the
hyoid bone, along with complete structural and functional
differentiation. Third, the thyroid primordium may not have
been able to detach from the pharyngeal floor and migrate,
promoting a lingual thyroid with a complete structural and
functional differentiation as observed in patients 3, 4, 5, and
6. Thus, the arrest of this process may have occurred earlier,
at 26 days of gestation, when migration begins [1].
To assess potential somatic genetic causes of TD in
protein-coding regions and 5’UTRs, expanded exome analy-
sis was performed in samples 2 and 4. Unfortunately the poor
quality of the DNA from paraffin tissues from the other sam-
ples did not allow performing the genetic analysis. Despite
the different exome-sequencing analysis approaches, no rele-
vant somatic mutations were identified in the sequenced
regions. A similar result was also obtained in a previous study
that investigated somatic mutations in monozygotic twins
discordant to TD [56]. On the other hand, WES identified
novel missense mutations in the BOREALIN gene in a con-
sanguineous family with TD [16] and DUOX2 mutations in
the N-terminal domain that may play a role in thyroid devel-
opment in sporadic TD cases [17], confirming the genetic
heterogeneity of this pathology. Furthermore, the involve-
ment of other genetic mechanisms may be also considered.
Novel copy number variations (CNVs), not described in the
healthy population, were identified in 8.75% of 80 TD
patients [54, 56]. No differences in the CpG island methyla-
tion of promoter regions were observed between normal
eutopic and ectopic thyroid tissues [22, 57]. Thus, the cause
of TD could be associated with molecular alterations in other
regions of the genoma or with polygenic or other epigenetic
alterations, or it could be purely stochastic.
In conclusion, no somatic mutations in the sequenced
regions were associated with ectopic thyroid. This is the first
description of fetal histopathological architecture in an adult
ectopic thyroid due to the arrest of structural differentiation
of the developing gland along with the arrest of migration
that proved able to synthesize thyroid hormone but not to
respond to TSH. We showed the ability of the ectopic thy-
roids to express specific thyroid genes and T4, despite the
migratory and histological differentiation defects, as well as
the ability to synthesize the thyroid hormone for at least
some period of the patient’s life.
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